AB

Alexandre Bragadir

Senior Investment Director

JC

Jean-Philippe Carvaillo

Senior Investment Director

Edouard Guillet

MD and Founding Partner

RG

Raeto Guler

Partner

Claire Lorenzi

CFO

EM

Eleonore Maguin

Investment Associate

Georges Ralli

Partner

RS

Rémi Spagnol

Investment Principal

BW

Bernice Welles

Partner

23 past transactions

Caresyntax

Series C in 2021
At caresyntax, your core mission is to bridge the variability gap of processes and outcomes in surgery and interventional radiology. We raise the surgical performance bar by empowering clinicians with actionable, enterprise-level data analytics.
Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline focusing on acute organ traumas, vascular damage and cancer immunotherapy.

SpineGuard

Post in 2016
The primary objective of SpineGuard is to establish PediGuard® as the STANDARD OF CARE FOR SAFER PEDICLE SCREW PLACEMENT to the benefit of patients, surgeons and health care providers as well as the shareholders, employees and partners of SpineGuard. Secondarily, SpineGuard is exploring other applications for the PediGuard technology platform provided that they are in line with the SpineGuard mission.

Genesis Automation Healthcare

Venture Round in 2018
Genesis provide innovative healthcare value-chain solutions which improve patient safety, cut costs and eliminate waste for both healthcare and technology providers.

Caresyntax

Series C in 2021
At caresyntax, your core mission is to bridge the variability gap of processes and outcomes in surgery and interventional radiology. We raise the surgical performance bar by empowering clinicians with actionable, enterprise-level data analytics.

Lumeon

Series D in 2020
Lumeon Ltd., a digital health company, provides care pathway management solutions to the healthcare industry. The company offers Care Pathway Manager, a cloud-based platform that provides a single real-time view of patient journey from referral to outcome. Its services include business analysis, project management, configuration and data migration, training, and support. Lumeon Ltd. was formerly known as Qinec Ltd. and changed its name to Lumeon Ltd. in July 2016. The company was founded in 2005 and is based in London, United Kingdom.

Poxel S.A.

Post in 2022
Poxel is a dynamic biopharmaceutical company developing innovative drugs for metabolic diseases, with a focus on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Based in Lyon, France, Poxel was spun out in 2009 from Merck Serono, a global leader in the field of metabolic disorders at that time. They believe that targeting cellular energy regulation pathways for the treatment of metabolic diseases, including type 2 diabetes is of critical importance as disbalances are at the root of those diseases. All three of their clinical stage pipeline programs address significant targets in the energy metabolism pathways. Imeglimin, their lead program, targets mitochondrial dysfunction, mitochondria being the power station of the cell, PXL770 activates the adenosine monophosphate-activated protein kinase (AMPK), an important energy sensor, and PXL065 (DRX-065) inhibits the mitochondrial pyruvate carrier (MPC).

Mainstay Medical

Post in 2015
Mainstay Medical Holdings plc, together with its subsidiaries, operates as a medical device company in Ireland, the United States, and Australia. It focuses on developing and commercializing ReActiv8, an implantable neurostimulation system designed to treat people with chronic low back pain by helping to restore control to the muscles that dynamically stabilise the lumbar spine. Mainstay Medical Holdings plc was founded in 2008 and is headquartered in Dublin, Ireland.

SpineGuard

Post in 2018
The primary objective of SpineGuard is to establish PediGuard® as the STANDARD OF CARE FOR SAFER PEDICLE SCREW PLACEMENT to the benefit of patients, surgeons and health care providers as well as the shareholders, employees and partners of SpineGuard. Secondarily, SpineGuard is exploring other applications for the PediGuard technology platform provided that they are in line with the SpineGuard mission.

Mendor

Venture Round in 2014
Mendor is a Finnish company, committed to the design, development and marketing of advanced diabetes management products. Mendor has launched a revolutionary, discreet, easy to use, portable all-in-one blood glucose meter and web-based software application for the daily management of diabetes. Mendor has designed its products together with users and diabetes experts to address the needs of people with diabetes requiring regular blood glucose monitoring.

Cassini Technologies

Debt Financing in 2016
Cassini Technologies B.V. operates as a medical device company engaged in developing corneal diagnostic solutions. The company was founded in 2013 and is based in 's-Gravenhage, the Netherlands.

Lumeon

Series C in 2018
Lumeon Ltd., a digital health company, provides care pathway management solutions to the healthcare industry. The company offers Care Pathway Manager, a cloud-based platform that provides a single real-time view of patient journey from referral to outcome. Its services include business analysis, project management, configuration and data migration, training, and support. Lumeon Ltd. was formerly known as Qinec Ltd. and changed its name to Lumeon Ltd. in July 2016. The company was founded in 2005 and is based in London, United Kingdom.

EOS Imaging

Post in 2015
EOS imaging is a medical company revolutionizing the treatment continuum for the most common osteoarticular conditions (hip, knee and spine) and associated orthopedic surgeries. Its EOS® 2D/3D imaging system is specifically adapted to the needs of orthopedic surgeons and radiologists. This personalized imaging tool gives a precise 3D image of the patient's skeleton in the upright position that can be used to inform all aspects of care. The Company has obtained authorization to market the system in 48 countries. The Company is based in Paris, with a subsidiary in the United States in Cambridge, Massachusetts, as well as offices in Montreal (Canada) and Germany.

Lumeon

Debt Financing in 2017
Lumeon Ltd., a digital health company, provides care pathway management solutions to the healthcare industry. The company offers Care Pathway Manager, a cloud-based platform that provides a single real-time view of patient journey from referral to outcome. Its services include business analysis, project management, configuration and data migration, training, and support. Lumeon Ltd. was formerly known as Qinec Ltd. and changed its name to Lumeon Ltd. in July 2016. The company was founded in 2005 and is based in London, United Kingdom.

Caresyntax

Venture Round in 2019
At caresyntax, your core mission is to bridge the variability gap of processes and outcomes in surgery and interventional radiology. We raise the surgical performance bar by empowering clinicians with actionable, enterprise-level data analytics.

Impeto Medical SAS

Debt Financing in 2016
Impeto Medical is a privately owned medical device company formed in June 2005 with its corporate headquarters in Paris, France. Impeto Medical manufactures and markets devices designed for non-invasive assessment of eccrine sweat gland activity.

Neuravi

Debt Financing in 2016
Neuravi Limited designs and develops clot retrieval devices for restoring blood flow in patients who have suffered ischemic strokes due to blockage of an artery to the brain. It offers EmboTrap revascularization devices for the treatment of acute ischemic strokes to patients in Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Spain, Sweden, and Switzerland. The company was incorporated in 2009 and is based in Galway, Ireland. As of April 10, 2017, Neuravi Limited operates as a subsidiary of DePuy Ireland Unlimited Company.
Mauna Kea Technologies SA develops and markets medical devices for the diagnosis and treatment of cancers and other diseases in Europe, the Middle East, Africa, the United States, Latin America, China, and Japan. Its flagship product is Cellvizio, a multidisciplinary probe and needle-based confocal laser endomicroscopy platform, which provides physicians and researchers with images of tissues at the cellular level. The company was founded in 2000 and is headquartered in Paris, France.

SpineGuard

Debt Financing in 2016
The primary objective of SpineGuard is to establish PediGuard® as the STANDARD OF CARE FOR SAFER PEDICLE SCREW PLACEMENT to the benefit of patients, surgeons and health care providers as well as the shareholders, employees and partners of SpineGuard. Secondarily, SpineGuard is exploring other applications for the PediGuard technology platform provided that they are in line with the SpineGuard mission.

i-Optics B.V.

Venture Round in 2015
i-Optics B.V., a medical device company, manufactures and distributes optical devices. It offers Cassini, a corneal shape analyzer to measures axis, magnitude, and accuracy, as well as capture data; and EasyScan, a retinal imaging system. The company was founded in 2003 and is based in The Hague, the Netherlands.

Genesis Automation

Venture Round in 2018
Genesis Automation is a single source, full-service automated system solutions provider. It designs and builds high-precision assembly, test, and special process equipment for a wide range of industries. Genesis Automation was founded in 1999 and is based in Cork, Ireland.

Bonesupport Holding AB (publ)

Debt Financing in 2013
BONESUPPORT is a medical technology company dedicated to the development of injectable osteoconductive biomaterials for the treatment of fragility fractures caused by osteoporosis, and bone voids or gaps caused by trauma, disease or related to surgical procedures. The company's mission is to restore health to enhance the quality of life for patients with bone disorders. BONESUPPORT was founded on 2000 and is headquartered in Lund, Sweden.

Genesis Automation Healthcare

Debt Financing in 2016
Genesis provide innovative healthcare value-chain solutions which improve patient safety, cut costs and eliminate waste for both healthcare and technology providers.